Grundinformationen
- Standard-SMILES
O=C(O)CCCCCc1cccc2cncn12- InChIKey
LIFOFTJHFFTNRV-UHFFFAOYSA-N- Summenformel
- C13H16N2O2
- Durchschnittliche Molmasse
- 232,28 g/mol
- Monoisotopische Masse
- 232,12117775
Überblick
Pirmagrel is a small molecule drug. Pirmagrel has a monoisotopic molecular weight of 232.12 Da.
Namen und Bezeichner
- Bevorzugter Name
- Pirmagrel
- IUPAC
- 6-imidazo[1,5-a]pyridin-5-ylhexanoic acid
- Englischer Name
- Pirmagrel
- Summenformel
- C13H16N2O2
- Molmasse
- 232.28
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
85691-74-3- PubChem CID
- 55390
- DTXSID
DTXSID80234982- ChEMBL
CHEMBL48092- UNII
- 9J5H2VA91V
- Nikkaji
- J22.080I
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 2,9
- Polarare Oberfläche (TPSA)
- 54,6 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 3
- Frei drehbare Bindungen
- 6
- Schwere Atome
- 17
- Formalladung
- 0
- Komplexität
- 258
Chemie und Industrie
Pharmakologische Informationen
MeSH Pharmacological Classification
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.
Anwendungen
VerwendenPirmagrel is an antithrombotic agent that treats thrombosis and ischaemic heart disorders.
Anbieter6 Anbieter
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…